Disciplines: Pharmacists
Hours: 4 Contact Hours
Author(s): C. Michael White, PharmD, FCP, FCCP
Peer Reviewer(s):Jason Cross, PharmD
Item#: Y8003
Contents: 1 Course Book (38 pages)
Western Schools is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

Antiplatelet Therapy: Implications for Patient Management



Price $32.95
Item # Y8003
New
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Start Date: September 16, 2016

Expiration Date: September 15, 2019

Antiplatelet medications are commonly used in cardiovascular disorders and are among the most commonly utilized medications in the country. The drugs are sometimes used alone but other times are used in combination to achieve optimal benefits. With both intravenous and oral agents, the clinician must understand the interplay between intravenous and oral therapy and the nuances of dual therapy versus monotherapy. In addition, the clinician must understand the critical differences in pharmacologic and pharmacokinetic parameters of these agents to ensure selection of the one option that is superior to the others or appropriate patient monitoring.

This course is designed for clinicians who provide care to patients currently taking antiplatelet medications. The purpose of this course is to increase clinicians’ knowledge of antiplatelet medications so that they can identify the optimal therapy and safely utilize these medications.

The information in this course was current at the time of publication. Pharmacotherapy is rapidly changing, new pharmaceutical agents are continuously being developed and approved, and older agents are being investigated in new ways; therefore, the clinician should stay abreast of new medications and ongoing research findings and their implications in the delivery of patient care.

Universal Activity Number (UAN) - 0607-0000-16-011-H01-P

Type of Activity - Knowledge

Topic Designator - 01

Course Objectives
  • Describe the contemporary role of antiplatelet medications in patients with coronary, cerebrovascular, and peripheral vascular disorders.
  • Describe current controversies in the duration of dual antiplatelet therapy.
  • Identify similarities and differences between different antiplatelet agents.
  • Describe how a pharmacist can utilize the information to optimize patient outcomes.

C. Michael White, PharmD, FCP, FCCP, is professor and chair of the University of Connecticut School of Pharmacy’s Department of Pharmacy Practice in Storrs, Connecticut and Codirector of the Health Outcomes, Policy, and Evidence Synthesis research group at Uconn and Hartford Hospital in Hartford, Connecticut, which houses one of only 13 Agency for Healthcare Research and Quality designated Evidence-Based Practice Centers. Dr. White received his BS Pharm and PharmD degrees from the Albany College of Pharmacy in Albany, New York, and completed a cardiovascular clinical pharmacology fellowship at Hartford Hospital in Hartford, Connecticut. Dr. White has published more than 150 peer-reviewed articles, including publications in JAMA, Annals of Internal Medicine, Circulation, and Lancet. His research has been selected for the American Society of Health Systems Pharmacists Drug Therapy Research Award and the American Association of Colleges of Pharmacy Lyman Award. He is an American College of Clinical Pharmacy Young Investigator of the Year recipient and fellow of the American College of Clinical Pharmacologists and American College of Clinical Pharmacists. He is a contributing editor of the Annals of Pharmacotherapy, is on the editorial board for Pharmacy Practice News, and hosts a once-weekly show called “Ask the Pharmacist” on FOX61 in Hartford, Connecticut.

Jason Cross, PharmD, is an Associate Professor of Pharmacy Practice at MCPHS-University (Worcester/Manchester Campus). He completed his PharmD at The University of Rhode Island College of Pharmacy in 2001 and then completed a pharmacy practice residency at Umass Medical School/Umass Memorial Medical Center. Since 2002, he has been a faculty member at MCPHS, where he has maintained practice sites in ambulatory care, critical care, and adult internal medicine. Dr. Cross facilitates several courses within the Doctor of Pharmacy, Master of Physician Assistant, and Doctor of Physical Therapy programs. Dr. Cross currently practices adult internal medicine at Baystate Medical Center and is the Assistant Director of the Pharmacy Practice Residency.

  • Contact hours will be awarded for up to one (1) year from date of purchase or by the expiration date indicated above, whichever date comes first.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.